S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells

Cancer

Volumn 85, Issue 2, 1999, Pages 309-317

  Yamane, Nariyuki ^a   Makino, Masato ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Apoptosis; DNA ploidy; Flow cytometry; Human colorectal cancer

Indexed keywords

FLUOROURACIL; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PLOIDY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

APOPTOSIS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; IMMUNOASSAY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PREOPERATIVE CARE; S PHASE;

EID: 0032917614     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<309::AID-CNCR7>3.0.CO;2-X     Document Type: Article

References (36)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993;67:205-8.
3. Kerr JFR, Winterford CM, Hamon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013-36.
4. Williams GT. Programmed cell deth: apoptosis and oncogenesis. Cell 1991;65:1097-8.
5. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling. Int J Cancer 1996;65: 173-7.
6. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990;2:275-80.
7. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993;53:1853-61.
8. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z. The cell cycle-related difference in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 1993;53:3186-92.
9. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
10. Makino M, Shirai H, Sugamura K, Kimura O, Maeta M, Itoh H, et al. Increased induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil. Oncol Rep 1996;3:281-5.
11. Sugamura K, Makino M, Shirai H, Kimura O, Maeta M, Itoh H, et al. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil. Cancer 1997;79:12-7.
12. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
13. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
14. Shan-Rong S, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
15. Sasaki K, Hashimoto T, Kawachino K, Takahashi M. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas. Cancer 1988;62:2569-75.
16. Kosugi Y, Ikebe J, Sekine M, Musha T, Shitara N, Kohono T, et al. Computer aided analysis of cell cycle phase from cytophotometric histogram. Trans Biomed Eng 1978;25:429-34.
17. Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling. Jpn J Cancer Res 1994;85:939-45.
18. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L, et al. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 1984;44:4144-50.
19. Wilkinson DS, Pilot HC. Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. J Biol Chem 1973;248:63-8.
20. Cory JG, Breland JC, Carter GL. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res 1979;39:4905-13.
21. Schuetz JD, Wallace HJ, Diasio RB. 5-fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Res 1984;44:1358-63.
22. O'Dwyer PJ, King SA, Hoth DF, Leyland-Jones B. Role of thymidine in biochemical modulation: a review. Cancer Res 1987;47:3911-19.
23. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, et al. Deoxyribonucleocide triphosphate imbalance: 5-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 1987;262:8235-41.
24. Koury MJ, Home DW. Apoptosis mediates and thymidine prevents erythroblast destruction in folate deficiency anemia. Proc Natl Acad Sci USA 1994;91:4067-71.
25. Pinendo HM, Peters GFJ. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988;6:1653-64.
26. Elstein KH, Zucker RM, Shuey DL, Lau C, Chernoff N, Rogers JM. Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil. Teratology 1993;48:75-87.
27. Elstein KH, Zucker RM, Andrews JE, Ebron-McCoy M, Shuey DL, Rogers JM. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations. Teratology 1993;48: 355-63.
28. Shuey DL, Lau C, Longsdon TR, Zucker RM, Elstein KH, Narotsky MG, et al. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol 1994;126:129-44.
29. Pickard M, Dive C, Kinsella AR. Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis. Br J Cancer 1995;72:1389-96.
30. Inada T, Ichikawa A, Igarashi S, Kubota T, Ogata Y. Effect of preoperative 5-fluorouracil on apoptosis of advanced gastric cancer. J Surg Oncol 1997;65:106-10.
31. Key G, Becher MHG, Duchrow M, Schluter C, Gerdes J. New Ki-67 equivalent murine monoclonal antibodies (MIB-1-3) prepared against recombinant parts of Ki-67 antigen. Anal Cell Pathol 1992;4:181.
32. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984;311:231-5.
33. Kotake K, Koyama Y, Namba M, Sunagawa M, Ito M, Kadowaki A, et al. Neoadjuvant chemotherapy with tegafur suppository for rectal cancer-Effects of tegafur on nuclear DNA content of cancer cells-. Jpn J Cancer Chemother 1995;22: 793-8.
34. Tadaoka N, Takayama S, Sekine C, Fujimori T, Nimura H, Tsutsumi J, et al. Effect of neoadjuvant chemotherapy (CDDP - UFT) upon cell DNA analysis by flow cytometry in gastric carcinoma. Jpn J Chemother 1993;20:799-803.
35. Volm M, Efferth T. Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests. Cytometry 1990;11:406-10.
36. Jacobsen AB, Berner A, Juul M, Ous S, Petterson EO, Fossa SD. DNA flow cytometry and neo-adjuvant chemotherapy / radiotherapy in operable muscle-invasive bladder carcinoma. Eur Urol 1992;22:316-22.